Comprehensive genomic profiling (CGP) examines the mutational status of hundreds of genes for oncology patients and is used most often in late-stage cancers. The results, paired with clinical information, support precision medicine-based treatment approaches.

And yet there are hurdles to broader adoption of this innovation. 

In our webinar titled, Unleashing the Power of Real-World Data Clinico Genomic Data in Advancing Oncology, Suzzette Arnal, Senior Director of Precision Medicine at The US Oncology Network, and Emily Paul, Director of Clinico-Genomics at Ontada, shared the challenges and benefits of Comprehensive Genomic Profiling (CGP) and how it is advancing precision oncology from both the provider and life sciences lens.

In this webinar, you will learn:

• The value of clinico-genomic data for both providers and life sciences
• Why diversity in clinico-genomic data is important
• How clinico-genomic data can help better design clinical trials
• How genomics data is affecting testing at the point of care and what it means for precision medicine